Literature DB >> 22544748

Depletion of p31comet protein promotes sensitivity to antimitotic drugs.

Hoi Tang Ma1, Yan Yan Chan, Xiao Chen, Kin Fan On, Randy Y C Poon.   

Abstract

Antimitotic spindle poisons are among the most important chemotherapeutic agents available. However, precocious mitotic exit by mitotic slippage limits the cytotoxicity of spindle poisons. The MAD2-binding protein p31(comet) is implicated in silencing the spindle assembly checkpoint after all kinetochores are attached to spindles. In this study, we report that the levels of p31(comet) and MAD2 in different cell lines are closely linked with susceptibility to mitotic slippage. Down-regulation of p31(comet) increased the sensitivity of multiple cancer cell lines to spindle poisons, including nocodazole, vincristine, and Taxol. In the absence of p31(comet), lower concentrations of spindle poisons were required to induce mitotic block. The delay in checkpoint silencing was induced by an accumulation of mitotic checkpoint complexes. The increase in the duration of mitotic block after p31(comet) depletion resulted in a dramatic increase in mitotic cell death upon challenge with spindle poisons. Significantly, cells that are normally prone to mitotic slippage and resistant to spindle disruption-mediated mitotic death were also sensitized after p31(comet) depletion. These results highlight the importance of p31(comet) in checkpoint silencing and its potential as a target for antimitotic therapies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22544748      PMCID: PMC3375577          DOI: 10.1074/jbc.M112.364356

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  The Mad2 spindle checkpoint protein undergoes similar major conformational changes upon binding to either Mad1 or Cdc20.

Authors:  Xuelian Luo; Zhanyun Tang; Josep Rizo; Hongtao Yu
Journal:  Mol Cell       Date:  2002-01       Impact factor: 17.970

2.  Identification of a MAD2-binding protein, CMT2, and its role in mitosis.

Authors:  Toshiyuki Habu; Sang Hoon Kim; Jasminder Weinstein; Tomohiro Matsumoto
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

3.  Degradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2.

Authors:  C H Yam; W Y Siu; A Lau; R Y Poon
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

4.  Conformation-specific binding of p31(comet) antagonizes the function of Mad2 in the spindle checkpoint.

Authors:  Guohong Xia; Xuelian Luo; Toshiyuki Habu; Josep Rizo; Tomohiro Matsumoto; Hongtao Yu
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

5.  Kinetochore localization of spindle checkpoint proteins: who controls whom?

Authors:  Suzanne Vigneron; Susana Prieto; Cyril Bernis; Jean-Claude Labbé; Anna Castro; Thierry Lorca
Journal:  Mol Biol Cell       Date:  2004-07-21       Impact factor: 4.138

Review 6.  Microtubules as a target for anticancer drugs.

Authors:  Mary Ann Jordan; Leslie Wilson
Journal:  Nat Rev Cancer       Date:  2004-04       Impact factor: 60.716

7.  Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation.

Authors:  R Y Poon; H Toyoshima; T Hunter
Journal:  Mol Biol Cell       Date:  1995-09       Impact factor: 4.138

8.  Homeostatic control of mitotic arrest.

Authors:  Gianluca Varetti; Claudia Guida; Stefano Santaguida; Elena Chiroli; Andrea Musacchio
Journal:  Mol Cell       Date:  2011-12-09       Impact factor: 17.970

9.  Cyclin F is degraded during G2-M by mechanisms fundamentally different from other cyclins.

Authors:  Tsz Kan Fung; Wai Yi Siu; Cain H Yam; Anita Lau; Randy Y C Poon
Journal:  J Biol Chem       Date:  2002-07-16       Impact factor: 5.157

10.  Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms.

Authors:  Wai Yi Siu; Anita Lau; Talha Arooz; Jeremy P H Chow; Horace T B Ho; Randy Y C Poon
Journal:  Mol Cancer Ther       Date:  2004-05       Impact factor: 6.261

View more
  18 in total

Review 1.  Mitotic checkpoint defects: en route to cancer and drug resistance.

Authors:  Sinjini Sarkar; Pranab Kumar Sahoo; Sutapa Mahata; Ranita Pal; Dipanwita Ghosh; Tanuma Mistry; Sushmita Ghosh; Tanmoy Bera; Vilas D Nasare
Journal:  Chromosome Res       Date:  2021-01-06       Impact factor: 5.239

2.  Genome-wide siRNA screen reveals coupling between mitotic apoptosis and adaptation.

Authors:  Laura A Díaz-Martínez; Zemfira N Karamysheva; Ross Warrington; Bing Li; Shuguang Wei; Xian-Jin Xie; Michael G Roth; Hongtao Yu
Journal:  EMBO J       Date:  2014-07-14       Impact factor: 11.598

Review 3.  Spatiotemporal regulation of the anaphase-promoting complex in mitosis.

Authors:  Sushama Sivakumar; Gary J Gorbsky
Journal:  Nat Rev Mol Cell Biol       Date:  2015-02       Impact factor: 94.444

4.  Coordinated regulation of p31(Comet) and Mad2 expression is required for cellular proliferation.

Authors:  Dipali A Date; Amy C Burrows; Monica Venere; Mark W Jackson; Matthew K Summers
Journal:  Cell Cycle       Date:  2013-10-15       Impact factor: 4.534

5.  TRIP13 is a protein-remodeling AAA+ ATPase that catalyzes MAD2 conformation switching.

Authors:  Qiaozhen Ye; Scott C Rosenberg; Arne Moeller; Jeffrey A Speir; Tiffany Y Su; Kevin D Corbett
Journal:  Elife       Date:  2015-04-28       Impact factor: 8.140

6.  The NOXA-MCL1-BIM axis defines lifespan on extended mitotic arrest.

Authors:  Manuel D Haschka; Claudia Soratroi; Susanne Kirschnek; Georg Häcker; Richard Hilbe; Stephan Geley; Andreas Villunger; Luca L Fava
Journal:  Nat Commun       Date:  2015-04-29       Impact factor: 14.919

7.  p31(comet) inactivates the chemically induced Mad2-dependent spindle assembly checkpoint and leads to resistance to anti-mitotic drugs.

Authors:  Toshiyuki Habu; Tomohiro Matsumoto
Journal:  Springerplus       Date:  2013-10-25

8.  Phosphorylation of Xenopus p31(comet) potentiates mitotic checkpoint exit.

Authors:  Min Mo; Alexei Arnaoutov; Mary Dasso
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

9.  Dovitinib induces mitotic defects and activates the G2 DNA damage checkpoint.

Authors:  Wing Yu Man; Joyce P Y Mak; Randy Y C Poon
Journal:  J Cell Mol Med       Date:  2013-11-18       Impact factor: 5.310

10.  Salt-inducible kinase 3 is a novel mitotic regulator and a target for enhancing antimitotic therapeutic-mediated cell death.

Authors:  H Chen; S Huang; X Han; J Zhang; C Shan; Y H Tsang; H T Ma; R Y C Poon
Journal:  Cell Death Dis       Date:  2014-04-17       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.